Table 2.

Method of detection: association with breast cancer-specific mortality

Cohort5-year breast cancer–specific survival*HR (95% CI)*HR (95% CI)
No. (%)
All women
    Screen-detected2,269 (58.3)93.81.01.0
    Symptomatic1,622 (41.7)84.62.3 (1.9-2.6)1.6 (1.3-2.0)
Non-Hispanic white women:
    Screen-detected1,747 (60.6)94.51.01.0
    Symptomatic1,134 (39.4)86.32.1 (1.7-2.6)1.4 (1.1-1.8)
Hispanic women
    Screen-detected522 (51.7)91.51.01.0
    Symptomatic488 (48.3)80.72.7 (2.0-3.6)1.9 (1.3-2.8)
  • *Adjusted for age.

  • Adjusted for age, tumor size, lymph node status, histologic grade, and estrogen and progesterone receptor status.

  • P = 0.11 for difference between the two ethnicities in relative hazard associated with method of detection.